A previous study demonstrated that a higher density of tumour-infiltrating lymphocytes (TILs), especially CD8-positive T cells, surrounding CRC tumours was significantly associated with a better ICIs treatment response (112). The gene discussed is CD8A; the disease is colorectal carcinoma.